Cartalax Peptide

Product Overview

A fundamental standard in musculoskeletal and extracellular matrix research dictates that exploring advanced cartilage-targeted compounds requires complete structural integrity and verified chemical purity. The Cartalax formulation addresses these demanding benchmarks, serving as a highly purified synthetic peptide bioregulator developed for precise in vitro and in vivo laboratory modeling. Each vial provides pure Cartalax, stabilized as a vacuum freeze-dried (lyophilized) powder maintaining a verified purity profile of greater than 98%.

Cartalax is a short-chain synthetic tripeptide bioregulator composed of a precise sequence of three amino acids: L-Alanyl-L-Glutamyl-L-Aspartic acid (Ala-Glu-Asp). Characterized by its targeted low molecular weight, this molecule possesses distinct structural stability advantages over larger endogenous proteins. Because of its fractional molecular architecture, Cartalax bypasses the complex enzymatic degradation required by dense structural proteins, allowing it to penetrate connective tissue cellular environments rapidly and demonstrate high bioactivity without triggering non-specific immune responses.

Operating primarily as a tissue-specific signaling agent, Cartalax acts directly on the cellular pathways of chondrocytes and connective tissue fibroblasts. It interfaces with the DNA structure of these target cells to modulate epigenetic mechanisms, optimizing cellular protein synthesis and metabolic homeostasis within the extracellular matrix. Documented research demonstrates that Cartalax actively supports the regulation of cartilage tissue metabolism, helps maintain normal collagen and proteoglycan synthesis, and protects chondrocyte structures from inflammatory or oxidative stress. These diverse mechanisms allow for the precise investigation of targeted cartilage system recovery, joint tissue regeneration, and cellular longevity within controlled laboratory settings.

Product Specifications

• Form: Lyophilized (vacuum freeze-dried) powder
• Purity: Greater than 98% (verified by HPLC analysis)
• Peptide Class: Short-Chain Synthetic Peptide Bioregulator
• Target System: Chondrocytes, Cartilage Matrix, and Connective Tissues
• Primary Research Focus: Epigenetic Bioregulation, Extracellular Matrix Homeostasis, and Chondrocyte Longevity

Container Specifications

The physical attributes of the storage vessel directly impact the shelf life of the compound. All research environments should utilize clean, chemically inert containers. Glass vials provide the highest level of protection against gas permeability and chemical interaction, though high-density polypropylene tubes serve as a valid alternative. Keep all stored peptides away from automatic frost-free freezers, as their internal defrost cycles create regular temperature swings that compromise peptide longevity.